The proposed bill would update current statutes by introducing new restrictions on the use of public funds for genetic sequencing procedures. Specifically, it would prohibit payments for such procedures performed by companies domiciled in or substantially controlled by entities from foreign adversaries and instead insert companies domiciled in or controlled by foreign adversaries. This change aims to enhance national security by preventing public funds from being allocated to technologies associated with adversarial nations like China, Russia, and Iran. Additionally, the bill would clarify existing language by replacing terms such as "expend" with "spend" and modifying phrases related to surviving spouse health insurance coverage. It would also introduce definitions for key terms like "company," "domiciled," "foreign adversary," and "genetic sequencing", which were not previously defined in the statutes. These updates are intended to modernize the language of the statutes and ensure consistency in terminology while implementing new regulations regarding health coverage and public spending.

Statutes affected:
Introduced Version: 38-651, 38-651.01, 38-1114, 38-1141, 38-652, 15-388, 15-187.01, 38-656
House Engrossed Version: 38-651, 38-651.01, 38-1114, 38-1141, 38-652, 15-388, 15-187.01, 38-656